Home › Premature Birth › NCT06767293

I-InTERACT Preterm Parenting

I-InTERACT Preterm Parenting Randomized Controlled Trial

Who can join

Ages 3 to 8 · All sexes · Healthy volunteers welcome

Inclusion Criteria:

* Born at \< 32 weeks gestational age.
* Total T score of \> 55 on the Child Behavior Checklist Total or Externalizing Behavior Scales OR Total T score of \> 55 on the Eyberg Child Behavior Inventory total problem- or total intensity-scale.
* English is the primary spoken language in the home.

Exclusion Criteria:

* Is not 18 years or older.
* Participant will be excluded from the study if the child does not reside with the caregiver at least half-time; the caregiving situation is not stable (i.e., there must be no scheduled custody hearings).
* English is not the primary language spoken in the home.
* Caregivers with a psychiatric hospitalization in the past year.

About the study

Many children born very preterm experience behavior problems, and existing resources for parenting these children are lacking. A pilot trial established the effectiveness of a preterm parenting intervention, I-Interact Preterm (I2P). This study proposes a three-arm randomized controlled trial (RCT) comparing the established seven-session I2P program, a microlearning delivery mode (I2P-Micro), and an internet resource comparison group (IRC). Outcomes will be assessed at pretreatment, post-treatment (12 weeks later), and at an extended follow-up six months post-randomization. These outcomes include parenting behaviors, child behavior problems, and parent distress. It is anticipated that both I2P and I2P-Micro will result in significant improvements relative to the IRC condition, with greater utilization expected in the I2P-Micro group.

What is being tested

• I-InTERACT Parenting Intervention (I2P) and coaching sessions (behavioral)
• I-InTERACT Parenting Microlearning Intervention (I2P Micro) and coaching sessions (behavioral)
• Internet Resources (other)

Sponsor: Children's Hospital Medical Center, Cincinnati · Participants: 90 · Started: Nov 27, 2024

Contact the study team

• Shari Wade, PhD · Phone: 5134610952
• Kaylen McCullough, BS · Phone: 8595336164

Official record on ClinicalTrials.gov — NCT06767293

Locations in the U.S.

Conditions

• Premature Birth

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.